Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Iron Overload 1

Interventions

Cyclophosphamide 15Antilymphocyte Serum 11fludarabine phosphate 10Cyclosporine 9Busulfan 9Peripheral Blood Stem Cell Transplantation 8Mycophenolic Acid 7Filgrastim 7Methotrexate 6Whole-Body Irradiation 5Melphalan 5fludarabine 4Radiotherapy 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4Tacrolimus 3Psychiatric Rehabilitation 3Palliative Care 3Blood Specimen Collection 3sargramostim 2Thiotepa 2Therapeutics 2Stem Cell Transplantation 2Polymerase Chain Reaction 2Injections 2Granulocyte Colony-Stimulating Factor 2Dexamethasone 2Cytarabine 2Behavior Therapy 2Ascorbic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Myelodysplastic Syndromes × Deferoxamine × Clear all
NCT00658411 2013-04-09

Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation

Dana-Farber Cancer Institute

Phase NA Terminated
5 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Iron Overload, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡